| Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation S Banerjee, G Sindberg, F Wang, J Meng, U Sharma, L Zhang, P Dauer, ... Mucosal immunology 9 (6), 1418-1428, 2016 | 237 | 2016 |
| Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters P Dauer, A Nomura, A Saluja, S Banerjee Pancreatology 17 (1), 7-12, 2017 | 145 | 2017 |
| Inactivation of cancer-associated-fibroblasts disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression P Dauer, X Zhao, VK Gupta, N Sharma, K Kesh, P Gnamlin, V Dudeja, ... Cancer research 78 (5), 1321-1333, 2018 | 107 | 2018 |
| ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness” P Dauer, NS Sharma, VK Gupta, B Durden, R Hadad, S Banerjee, ... Cell death & disease 10 (2), 132, 2019 | 89 | 2019 |
| Inhibition of NF-kappa B pathway leads to deregulation of epithelial–mesenchymal transition and neural invasion in pancreatic cancer A Nomura, K Majumder, B Giri, P Dauer, V Dudeja, S Roy, S Banerjee, ... Laboratory investigation 96 (12), 1268-1278, 2016 | 88 | 2016 |
| O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability NS Sharma, VK Gupta, P Dauer, K Kesh, R Hadad, B Giri, A Chandra, ... Theranostics 9 (12), 3410, 2019 | 55 | 2019 |
| NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling A Nomura, VK Gupta, P Dauer, NS Sharma, V Dudeja, N Merchant, ... Molecular cancer research 16 (1), 162-172, 2018 | 55 | 2018 |
| Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity VK Gupta, NS Sharma, K Kesh, P Dauer, A Nomura, B Giri, V Dudeja, ... Cancer letters 439, 101-112, 2018 | 53 | 2018 |
| Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells A Nomura, P Dauer, V Gupta, O McGinn, N Arora, K Majumdar, ... Oncotarget 7 (35), 56324, 2016 | 48 | 2016 |
| GRP 78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells P Dauer, NS Sharma, VK Gupta, A Nomura, V Dudeja, A Saluja, ... Molecular oncology 12 (9), 1498-1512, 2018 | 41 | 2018 |
| Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer O McGinn, VK Gupta, P Dauer, N Arora, N Sharma, A Nomura, V Dudeja, ... Scientific reports 7 (1), 7872, 2017 | 38 | 2017 |
| Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer P Dauer, VK Gupta, O McGinn, A Nomura, NS Sharma, N Arora, B Giri, ... Scientific reports 7 (1), 1564, 2017 | 31 | 2017 |
| Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer N Arora, O Alsaied, P Dauer, K Majumder, S Modi, B Giri, V Dudeja, ... PLoS One 12 (2), e0171827, 2017 | 31 | 2017 |
| Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum C Bisson, S Dautel, E Patel, S Suresh, P Dauer, S Rana Frontiers in Medicine 10, 1144170, 2023 | 26 | 2023 |
| Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol 9: 1418–1428 S Banerjee, G Sindberg, F Wang, J Meng, U Sharma, L Zhang, P Dauer, ... | 10 | 2016 |
| High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage … JA Crozier, J Barone, P Whitworth, A Cheong, R Maganini, JP Tamayo, ... Journal of Surgical Oncology 125 (4), 596-602, 2022 | 8 | 2022 |
| O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancer NS Sharma, VK Gupta, P Dauer, K Kesh, R Hadad, B Giri, A Chandra, ... bioRxiv, 345223, 2018 | 8 | 2018 |
| Bioflavonoid luteolin prevents sFlt-1 release via HIF-1α inhibition in cultured human placenta AC Eddy, CY Chiang, A Rajakumar, FT Spradley, P Dauer, JP Granger, ... The FASEB Journal, 2023 | 6 | 2023 |
| Genomic classification of HER2-positive patients with 80-gene and 70-gene signatures identifies diversity in clinical outcomes With HER2-targeted neoadjuvant therapy PW Whitworth, PD Beitsch, MK Murray, PD Richards, A Mislowsky, CL Dul, ... JCO Precision Oncology 6, e2200197, 2022 | 5 | 2022 |
| Tu1964 Minnelide: a novel therapeutic agent for gastric adenocarcinoma N Arora, O Alsaied, K Majumder, S Modi, P Dauer, S Banerjee, A Saluja Gastroenterology (New York, NY 1943) 148 (4), S-947-S-947, 2015 | 3 | 2015 |
